Advertisement
"This partnership with Novus represents a new opportunity for Martek,"said Joe Buron, vice president of sales and marketing for Martek. "Animal feedand nutrition represent a logical extension of Martek's core technology and weare pleased to be working with an industry leader and innovator like Novus aswe expand into this market."
Advertisement
DHA Gold(R) biomass animal feed ingredient is a dried, whole-cell algaeproduct used to provide DHA enrichment for commercially raised animals. AddingDHA Gold(R) to animal feed is a safe and effective way to enrich foods such asmeat, eggs and milk. DHA Gold(R) is unique in the market because it is from asustainable and vegetarian source, has a more stable and consistentcomposition than fish oil and fish byproducts, and is free of ocean-bornecontaminants.
Novus International, Inc. is headquartered in St. Louis, Missouri, U.S.A.and serves customers in more than 80 countries around the world. An industryleader in animal nutrition and health, Novus products include ALIMET(R) andMHA(R) feed supplements, ACTIVATE(R) nutritional feed acid, ACIDOMIX(TM)preservative premixture, ADVENT(R) coccidiosis control, MINTREX(R) organictrace minerals, SANTOQUIN(R) feed preservative and many other specialtyingredients. Arenus (www.arenusperformance.com), part of Novus International,Inc., focuses on developing performance products for the equine, canine, andhuman markets. Novus is privately owned by Mitsui and Co., Ltd. and NipponSoda Co., Ltd. For more information visit www.novusint.com.
Martek Biosciences Corporation (Nasdaq: MATK) is a leader in theinnovation and development of DHA omega-3 products that promote health andwellness through every stage of life. The company produces life'sDHA(TM)(www.lifesdha.com), a sustainable and vegetarian source of the omega-3 fattyacid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula,and supplements, and DHAGold(R), a sustainable and vegetarian source of DHAfor animal feed. The company also produces life'sARA(TM) (arachidonic acid),an omega-6 fatty acid, from a sustainable, vegetarian source, for use ininfant formula. For more information on Martek Biosciences Corporation, visithttp://www.martek.com.
Sections of this release contain forward-looking statements. Thesestatements are based upon numerous assumptions which Martek cannot control andinvolve risks and uncertainties that could cause actual results to differ.These statements should be understood in light of the risk factors set forthin the company's filings with the Securities and Exchange Commission,including, but not limited to, the company's Form 10-K for the fiscal yearended October 31, 2006 and other filed reports on Form 10-K, Form 10-K/A, Form10-Q and Form 8-K.Contact: Cassie France-Kelly Public Relations (443) 542-2116 [email protected] Kyle Stults Investor Relations (410) 740-0081 [email protected]
SOURCE Martek Biosciences Corporation
